| 000 | 01884 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515203810.0 | ||
| 264 | 0 | _c20110718 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1461-7285 | ||
| 024 | 7 |
_a10.1177/0269881109359099 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHood, S D | |
| 245 | 0 | 0 |
_aNoradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge. _h[electronic resource] |
| 260 |
_bJournal of psychopharmacology (Oxford, England) _cJan 2011 |
||
| 300 |
_a78-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-2 Receptor Agonists _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnxiety Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aClonidine _xpharmacology |
| 650 | 0 | 4 |
_aCyclohexanols _xpharmacology |
| 650 | 0 | 4 |
_aEye Movements _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Adrenergic _xphysiology |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aVenlafaxine Hydrochloride |
| 700 | 1 | _aMelichar, J K | |
| 700 | 1 | _aTaylor, L G | |
| 700 | 1 | _aKalk, N | |
| 700 | 1 | _aEdwards, T R | |
| 700 | 1 | _aHince, D A | |
| 700 | 1 | _aLenox-Smith, A | |
| 700 | 1 | _aLingford-Hughes, A R | |
| 700 | 1 | _aNutt, D J | |
| 773 | 0 |
_tJournal of psychopharmacology (Oxford, England) _gvol. 25 _gno. 1 _gp. 78-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0269881109359099 _zAvailable from publisher's website |
| 999 |
_c19469847 _d19469847 |
||